| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 1.25e-06 | 5 | 101 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 2.01e-05 | 11 | 101 | 3 | GO:0015217 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 4.39e-05 | 14 | 101 | 3 | GO:0005347 | |
| GeneOntologyMolecularFunction | protein kinase activity | STK36 CDC42BPA MARK1 NTRK3 ROR2 MKNK2 OBSCN NRP2 NEK4 CSK EEF2K DCLK1 | 5.06e-05 | 600 | 101 | 12 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | STK36 CDC42BPA HK3 MARK1 NTRK3 ROR2 MKNK2 OBSCN NRP2 NEK4 CSK EEF2K DCLK1 | 5.88e-05 | 709 | 101 | 13 | GO:0016773 |
| GeneOntologyMolecularFunction | DNA replication origin binding | 9.70e-05 | 18 | 101 | 3 | GO:0003688 | |
| GeneOntologyMolecularFunction | kinase activity | STK36 CDC42BPA HK3 MARK1 NTRK3 ROR2 MKNK2 OBSCN NRP2 NEK4 CSK EEF2K DCLK1 | 1.25e-04 | 764 | 101 | 13 | GO:0016301 |
| GeneOntologyMolecularFunction | triplex DNA binding | 1.51e-04 | 4 | 101 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 2.07e-04 | 23 | 101 | 3 | GO:0005346 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FLNB CLSTN3 OBSCN ITGA10 NIBAN2 TENM4 DST NUDC CDH4 CDH7 HCFC1 | 2.23e-04 | 599 | 101 | 11 | GO:0050839 |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 2.51e-04 | 5 | 101 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 2.51e-04 | 5 | 101 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 3.00e-04 | 26 | 101 | 3 | GO:0000295 | |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 3.75e-04 | 6 | 101 | 2 | GO:0016421 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 4.17e-04 | 29 | 101 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 4.68e-04 | 127 | 101 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 5.23e-04 | 7 | 101 | 2 | GO:0016885 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 6.14e-04 | 33 | 101 | 3 | GO:0015215 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | STK36 CDC42BPA HK3 MARK1 NTRK3 ROR2 MKNK2 OBSCN NRP2 NEK4 CSK EEF2K DCLK1 | 8.85e-04 | 938 | 101 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.01e-03 | 39 | 101 | 3 | GO:0015605 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 1.11e-03 | 10 | 101 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 1.35e-03 | 11 | 101 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 1.35e-03 | 11 | 101 | 2 | GO:0043139 | |
| GeneOntologyMolecularFunction | ferric iron binding | 1.35e-03 | 11 | 101 | 2 | GO:0008199 | |
| GeneOntologyMolecularFunction | neurotrophin binding | 1.62e-03 | 12 | 101 | 2 | GO:0043121 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.68e-03 | 339 | 101 | 7 | GO:0045296 | |
| GeneOntologyMolecularFunction | ligase activity | 1.91e-03 | 174 | 101 | 5 | GO:0016874 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.92e-03 | 446 | 101 | 8 | GO:0004674 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 2.22e-03 | 14 | 101 | 2 | GO:0051880 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 2.47e-03 | 363 | 101 | 7 | GO:0106310 | |
| GeneOntologyMolecularFunction | long-chain fatty acid-CoA ligase activity | 2.55e-03 | 15 | 101 | 2 | GO:0004467 | |
| GeneOntologyMolecularFunction | kinesin binding | 2.72e-03 | 55 | 101 | 3 | GO:0019894 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 3.33e-03 | 59 | 101 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 3.33e-03 | 59 | 101 | 3 | GO:0015932 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 1.03e-06 | 5 | 98 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 5.72e-06 | 8 | 98 | 3 | GO:1990544 | |
| GeneOntologyBiologicalProcess | ADP transport | 2.22e-05 | 12 | 98 | 3 | GO:0015866 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 4.54e-05 | 15 | 98 | 3 | GO:1901029 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CLSTN3 TSPOAP1 MARK1 NTRK3 UBE3B ROR2 ADCY1 FABP5 NRP2 TENM4 EEF2K GNAO1 DCLK1 | 1.39e-04 | 817 | 100 | 13 | GO:0098978 |
| Domain | Kinase-like_dom | STK36 CDC42BPA MARK1 NTRK3 ROR2 MKNK2 OBSCN NEK4 DST CSK EEF2K DCLK1 | 2.39e-05 | 542 | 97 | 12 | IPR011009 |
| Domain | Mit_uncoupling | 2.89e-05 | 12 | 97 | 3 | IPR002030 | |
| Domain | PROTEIN_KINASE_ATP | 1.36e-04 | 459 | 97 | 10 | PS00107 | |
| Domain | Protein_kinase_ATP_BS | 1.57e-04 | 379 | 97 | 9 | IPR017441 | |
| Domain | Carboxyl_trans | 1.59e-04 | 4 | 97 | 2 | PF01039 | |
| Domain | COA_CT_CTER | 1.59e-04 | 4 | 97 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 1.59e-04 | 4 | 97 | 2 | PS50980 | |
| Domain | COA_CT_N | 1.59e-04 | 4 | 97 | 2 | IPR011762 | |
| Domain | COA_CT_C | 1.59e-04 | 4 | 97 | 2 | IPR011763 | |
| Domain | Carboxyl_trans | 1.59e-04 | 4 | 97 | 2 | IPR000022 | |
| Domain | Prot_kinase_dom | 2.27e-04 | 489 | 97 | 10 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 2.42e-04 | 493 | 97 | 10 | PS50011 | |
| Domain | Rudment_hybrid_motif | 3.95e-04 | 6 | 97 | 2 | IPR011054 | |
| Domain | Aden_trnslctor | 4.05e-04 | 28 | 97 | 3 | IPR002113 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 4.56e-04 | 69 | 97 | 4 | IPR020636 | |
| Domain | Mit_carrier | 6.04e-04 | 32 | 97 | 3 | IPR002067 | |
| Domain | PROTEIN_KINASE_TYR | 1.64e-03 | 97 | 97 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.64e-03 | 97 | 97 | 4 | IPR008266 | |
| Domain | - | 2.01e-03 | 13 | 97 | 2 | 3.40.50.20 | |
| Domain | ATP_GRASP | 2.33e-03 | 14 | 97 | 2 | PS50975 | |
| Domain | ATP-grasp | 2.33e-03 | 14 | 97 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 2.33e-03 | 14 | 97 | 2 | IPR016185 | |
| Domain | Ser/Thr_kinase_AS | 2.59e-03 | 357 | 97 | 7 | IPR008271 | |
| Domain | - | 2.64e-03 | 53 | 97 | 3 | 1.50.40.10 | |
| Domain | Mito_carr | 2.64e-03 | 53 | 97 | 3 | PF00153 | |
| Domain | SOLCAR | 2.64e-03 | 53 | 97 | 3 | PS50920 | |
| Domain | Mitochondrial_sb/sol_carrier | 2.64e-03 | 53 | 97 | 3 | IPR018108 | |
| Domain | Mt_carrier_dom | 2.64e-03 | 53 | 97 | 3 | IPR023395 | |
| Domain | S_TKc | 2.67e-03 | 359 | 97 | 7 | SM00220 | |
| Domain | - | 2.68e-03 | 15 | 97 | 2 | 3.30.1490.20 | |
| Domain | PROTEIN_KINASE_ST | 2.80e-03 | 362 | 97 | 7 | PS00108 | |
| Domain | CADHERIN_1 | 2.86e-03 | 113 | 97 | 4 | PS00232 | |
| Domain | Cadherin | 2.86e-03 | 113 | 97 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 2.95e-03 | 114 | 97 | 4 | PS50268 | |
| Domain | - | 2.95e-03 | 114 | 97 | 4 | 2.60.40.60 | |
| Domain | CA | 3.04e-03 | 115 | 97 | 4 | SM00112 | |
| Domain | Cadherin-like | 3.14e-03 | 116 | 97 | 4 | IPR015919 | |
| Domain | Cadherin | 3.34e-03 | 118 | 97 | 4 | IPR002126 | |
| Domain | Pkinase | 3.71e-03 | 381 | 97 | 7 | PF00069 | |
| Domain | ATP_grasp_subdomain_1 | 3.87e-03 | 18 | 97 | 2 | IPR013815 | |
| Domain | - | 3.87e-03 | 18 | 97 | 2 | 3.30.470.20 | |
| Domain | DH_1 | 4.30e-03 | 63 | 97 | 3 | PS00741 | |
| Domain | - | 5.26e-03 | 21 | 97 | 2 | 3.90.226.10 | |
| Domain | ClpP/crotonase-like_dom | 5.26e-03 | 21 | 97 | 2 | IPR029045 | |
| Domain | RhoGEF | 5.33e-03 | 68 | 97 | 3 | SM00325 | |
| Domain | SH3 | 5.38e-03 | 216 | 97 | 5 | PS50002 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 1.62e-05 | 10 | 74 | 3 | M47694 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 2.95e-05 | 12 | 74 | 3 | M27728 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.82e-05 | 13 | 74 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 3.82e-05 | 13 | 74 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 3.82e-05 | 13 | 74 | 3 | M47703 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 4.85e-05 | 14 | 74 | 3 | M47692 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 6.04e-05 | 15 | 74 | 3 | M47691 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 7.40e-05 | 16 | 74 | 3 | MM1340 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.40e-05 | 16 | 74 | 3 | M47695 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.07e-04 | 18 | 74 | 3 | M47659 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 1.07e-04 | 18 | 74 | 3 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 1.27e-04 | 19 | 74 | 3 | M47677 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.27e-04 | 19 | 74 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 1.48e-04 | 20 | 74 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 1.73e-04 | 21 | 74 | 3 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.99e-04 | 22 | 74 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.99e-04 | 22 | 74 | 3 | M47675 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 1.99e-04 | 22 | 74 | 3 | M6327 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 2.28e-04 | 23 | 74 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.28e-04 | 23 | 74 | 3 | M47676 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | A2M SLC25A4 SLC25A5 SLC25A6 FTMT TF ADCY1 SLC1A5 SLC36A2 SLC5A3 CUTC NCEH1 | 4.16e-04 | 736 | 74 | 12 | M27287 |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 6.19e-04 | 131 | 74 | 5 | M5283 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 9.49e-04 | 37 | 74 | 3 | M1029 | |
| Pathway | WP_BIOTIN_METABOLISM_INCLUDING_IMDS | 9.56e-04 | 9 | 74 | 2 | M40064 | |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 1.19e-03 | 10 | 74 | 2 | MM1530 | |
| Pathway | BIOCARTA_ETC_PATHWAY | 1.19e-03 | 10 | 74 | 2 | M15371 | |
| Pathway | WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER | 1.38e-03 | 42 | 74 | 3 | M39740 | |
| Pathway | WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS | 1.45e-03 | 11 | 74 | 2 | M48094 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 1.45e-03 | 11 | 74 | 2 | M27086 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 1.45e-03 | 11 | 74 | 2 | MM15471 | |
| Pathway | REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM | 1.45e-03 | 11 | 74 | 2 | MM14764 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.47e-03 | 43 | 74 | 3 | M881 | |
| Pubmed | HSPD1 FLNB ACACB SLC25A4 SLC25A5 SLC25A6 TAF1B CCDC150 LYST DDX11 RBMXL2 DST SBNO1 DNAJC11 PCDHGB4 CHD6 GNAO1 ARHGEF4 ANAPC7 SMURF2 KPNB1 | 8.74e-10 | 1442 | 101 | 21 | 35575683 | |
| Pubmed | HSPD1 FLNB CDC42BPA SLC25A5 ERCC6L ROR2 GART NIBAN2 SLC1A5 CSDE1 DST CSK NUDC HCFC1 KPNB1 | 2.18e-09 | 708 | 101 | 15 | 39231216 | |
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 12450408 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 2.38e-08 | 3 | 101 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 2.38e-08 | 3 | 101 | 3 | 2829183 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 33396658 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | HSPD1 FLNB MAGEB4 SLC25A5 OBSCN SPAG9 ARHGEF17 PGM1 MSH6 TNFSF11 DST ADAMTS9 CHD6 | 2.27e-07 | 736 | 101 | 13 | 29676528 |
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 10620603 | ||
| Pubmed | 5.03e-07 | 327 | 101 | 9 | 31409639 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HSPD1 ACACB ERCC6L GART SPAG9 NIBAN2 SLC1A5 FABP5 CSDE1 MSH6 DST NUDC HCFC1 KPNB1 | 5.42e-07 | 934 | 101 | 14 | 33916271 |
| Pubmed | 5.57e-07 | 331 | 101 | 9 | 29199018 | ||
| Pubmed | HSPD1 GART NIBAN2 SLC1A5 PGM1 CSDE1 DNAJC11 SARDH HCFC1 KPNB1 | 8.17e-07 | 451 | 101 | 10 | 36168627 | |
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 21370995 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HSPD1 ACACB SLC25A4 SLC25A5 SLC25A6 GART MCCC2 TF SLC1A5 CSDE1 MSH6 DNAJC11 CHD6 NUDC HCFC1 KPNB1 | 1.27e-06 | 1318 | 101 | 16 | 30463901 |
| Pubmed | 1.32e-06 | 8 | 101 | 3 | 27641616 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.35e-06 | 477 | 101 | 10 | 31300519 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | HSPD1 HGD FLNB CDC42BPA ACSM1 SPAG9 NIBAN2 TF ADCY1 SLC36A2 PGM1 CSK N4BP2L2 KPNB1 | 1.46e-06 | 1016 | 101 | 14 | 19056867 |
| Pubmed | 1.56e-06 | 67 | 101 | 5 | 30669930 | ||
| Pubmed | HSPD1 FLNB SLC25A5 SLC25A6 GART SPAG9 NIBAN2 SLC1A5 CSK NCEH1 NUDC ANAPC7 KPNB1 | 1.63e-06 | 878 | 101 | 13 | 37223481 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | HSPD1 HK3 ACACB SLC25A4 PLGRKT ACSM1 RIPOR3 FTMT MCCC2 DNAJC11 DHODH SARDH SPRYD4 | 2.92e-06 | 926 | 101 | 13 | 20877624 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HSPD1 SLC25A4 SLC25A5 SLC25A6 GART MCCC2 SLC1A5 DDX11 CSDE1 MSH6 DNAJC11 NUDC ANAPC7 HCFC1 KPNB1 | 3.49e-06 | 1257 | 101 | 15 | 37317656 |
| Pubmed | IGSF8 HSPD1 FLNB SLC25A4 SLC25A5 MARK1 ARHGEF17 TF PGM1 CSDE1 TENM4 DST GNAO1 ARHGEF4 DCLK1 KPNB1 | 3.66e-06 | 1431 | 101 | 16 | 37142655 | |
| Pubmed | 5.13e-06 | 12 | 101 | 3 | 16120388 | ||
| Pubmed | 6.34e-06 | 568 | 101 | 10 | 37774976 | ||
| Pubmed | HSPD1 FLNB SLC25A4 SLC25A5 SLC25A6 GART SLC1A5 FABP5 RBMXL2 DST CSK KPNB1 | 6.38e-06 | 844 | 101 | 12 | 25963833 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 7.13e-06 | 91 | 101 | 5 | 28558017 | |
| Pubmed | Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | 7.34e-06 | 243 | 101 | 7 | 36964488 | |
| Pubmed | 7.54e-06 | 244 | 101 | 7 | 30349055 | ||
| Pubmed | Novel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability. | 7.62e-06 | 160 | 101 | 6 | 23798571 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 7.68e-06 | 344 | 101 | 8 | 36282215 | |
| Pubmed | Role of adenine nucleotide translocator 1 in mtDNA maintenance. | 8.35e-06 | 2 | 101 | 2 | 10926541 | |
| Pubmed | Characterization of two ENU-induced mutations affecting mouse skeletal morphology. | 8.35e-06 | 2 | 101 | 2 | 23979929 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 9172452 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26842067 | ||
| Pubmed | The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. | 8.35e-06 | 2 | 101 | 2 | 14749836 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 27048932 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16556444 | ||
| Pubmed | Human MRCKalpha is regulated by cellular iron levels and interferes with transferrin iron uptake. | 8.35e-06 | 2 | 101 | 2 | 20188707 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 2823266 | ||
| Pubmed | Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. | 8.35e-06 | 2 | 101 | 2 | 10974536 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 12112115 | ||
| Pubmed | A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. | 8.35e-06 | 2 | 101 | 2 | 11756613 | |
| Pubmed | 8.36e-06 | 94 | 101 | 5 | 36584595 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.00e-05 | 357 | 101 | 8 | 37059091 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | HSPD1 HK3 ACACB SLC25A4 SLC25A5 PLGRKT ACSM1 FTMT MCCC2 DNAJC11 DHODH SARDH SPRYD4 | 1.09e-05 | 1047 | 101 | 13 | 18614015 |
| Pubmed | 1.49e-05 | 377 | 101 | 8 | 25147182 | ||
| Pubmed | 1.85e-05 | 187 | 101 | 6 | 26460568 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 2.20e-05 | 288 | 101 | 7 | 31501420 | |
| Pubmed | HSPD1 FLNB SLC25A4 SLC25A5 SLC25A6 PLGRKT NRP2 NCEH1 NUDC DCLK1 KPNB1 | 2.24e-05 | 803 | 101 | 11 | 36517590 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HSPD1 FLNB SLC25A5 SLC25A6 GART NIBAN2 MCCC2 SLC1A5 MSH6 DST KPNB1 | 2.34e-05 | 807 | 101 | 11 | 30575818 |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 17611414 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 16831128 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 21854770 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | HSPD1 A2M FLNB SPAG9 TF SLC1A5 MSH6 CSK DNAJC11 NUDC SNTB1 KPNB1 | 2.64e-05 | 974 | 101 | 12 | 28675297 |
| Pubmed | HSPD1 FLNB CDC42BPA ACACB SLC25A5 TSPOAP1 MARK1 MCCC2 CSDE1 TENM4 DNAJC11 NUDC DCLK1 | 2.64e-05 | 1139 | 101 | 13 | 36417873 | |
| Pubmed | 2.78e-05 | 201 | 101 | 6 | 25192599 | ||
| Pubmed | 2.86e-05 | 202 | 101 | 6 | 24639526 | ||
| Pubmed | 3.29e-05 | 549 | 101 | 9 | 38280479 | ||
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 3.33e-05 | 125 | 101 | 5 | 36030824 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 3.73e-05 | 558 | 101 | 9 | 35063084 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 3.89e-05 | 315 | 101 | 7 | 26777405 | |
| Pubmed | HSPD1 SLC25A4 SLC25A5 OBSCN MCCC2 TF SLC1A5 PGM1 DNAJC11 GNAO1 HCFC1 | 4.13e-05 | 859 | 101 | 11 | 31536960 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDC42BPA ERCC6L NTRK3 ROR2 ARHGEF17 LYST SLC1A5 NEK4 DST ARHGEF4 DCLK1 | 4.21e-05 | 861 | 101 | 11 | 36931259 |
| Pubmed | 4.29e-05 | 320 | 101 | 7 | 28685749 | ||
| Pubmed | Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. | 4.60e-05 | 24 | 101 | 3 | 24725412 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 4.75e-05 | 444 | 101 | 8 | 34795231 | |
| Pubmed | Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. | 4.99e-05 | 4 | 101 | 2 | 19561643 | |
| Pubmed | Rapid evolution of human pseudoautosomal genes and their mouse homologs. | 4.99e-05 | 4 | 101 | 2 | 8903724 | |
| Pubmed | Human-Specific ARHGAP11B Acts in Mitochondria to Expand Neocortical Progenitors by Glutaminolysis. | 4.99e-05 | 4 | 101 | 2 | 31883789 | |
| Pubmed | Csk is constitutively associated with a 60-kDa tyrosine-phosphorylated protein in human T cells. | 4.99e-05 | 4 | 101 | 2 | 8621646 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 22423112 | ||
| Pubmed | Genome-wide association study identifies two loci strongly affecting transferrin glycosylation. | 4.99e-05 | 4 | 101 | 2 | 21665994 | |
| Pubmed | Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. | 4.99e-05 | 4 | 101 | 2 | 31489369 | |
| Pubmed | The ADP/ATP translocase drives mitophagy independent of nucleotide exchange. | 4.99e-05 | 4 | 101 | 2 | 31618756 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 11287411 | ||
| Pubmed | 5.21e-05 | 330 | 101 | 7 | 32529326 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 5.23e-05 | 583 | 101 | 9 | 29844126 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 5.52e-05 | 333 | 101 | 7 | 32665550 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSPD1 FLNB DNAH10 SLC25A5 GART MCCC2 SLC1A5 MSH6 SBNO1 DNAJC11 NUDC ANAPC7 HCFC1 KPNB1 | 6.46e-05 | 1425 | 101 | 14 | 30948266 |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | 6.86e-05 | 468 | 101 | 8 | 36042349 | |
| Pubmed | 7.20e-05 | 147 | 101 | 5 | 26465331 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HSPD1 A2M FLNB SLC25A5 SLC25A6 GART ITIH2 CSDE1 MSH6 DST DNAJC11 NUDC KPNB1 | 7.22e-05 | 1257 | 101 | 13 | 36526897 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HSPD1 FLNB GART SPAG9 NIBAN2 TBC1D17 CSDE1 CUTC MSH6 SBNO1 EEF2K NUDC HCFC1 KPNB1 | 8.06e-05 | 1455 | 101 | 14 | 22863883 |
| Pubmed | Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. | 8.30e-05 | 5 | 101 | 2 | 19252502 | |
| Pubmed | Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. | 8.30e-05 | 5 | 101 | 2 | 20383147 | |
| Pubmed | H+ transport is an integral function of the mitochondrial ADP/ATP carrier. | 8.30e-05 | 5 | 101 | 2 | 31341297 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | STK36 B4GALNT4 CDC42BPA UBE3B OBSCN LYST SLC1A5 TBC1D17 DST ARHGEF4 SMURF2 HCFC1 | 8.83e-05 | 1105 | 101 | 12 | 35748872 |
| Pubmed | 8.91e-05 | 248 | 101 | 6 | 32963011 | ||
| Pubmed | FLNB CLSTN3 DNAAF9 TF CSDE1 DST SBNO1 ADAMTS9 N4BP2L2 CHD6 SMURF2 DCLK1 KPNB1 | 9.00e-05 | 1285 | 101 | 13 | 35914814 | |
| Pubmed | TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. | 9.12e-05 | 30 | 101 | 3 | 23973329 | |
| Pubmed | HSPD1 FLNB NPR3 SLC25A6 GART MCCC2 ARHGEF17 SLC1A5 CSDE1 DST NCEH1 HCFC1 KPNB1 | 9.88e-05 | 1297 | 101 | 13 | 33545068 | |
| Pubmed | 1.01e-04 | 31 | 101 | 3 | 35066290 | ||
| Pubmed | 1.04e-04 | 638 | 101 | 9 | 33239621 | ||
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 1.06e-04 | 256 | 101 | 6 | 35777956 | |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 1.08e-04 | 84 | 101 | 4 | 25670202 | |
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | HSPD1 SLC25A4 SLC25A5 SLC25A6 PLGRKT ACSM1 FTMT MCCC2 DNAJC11 DHODH SARDH SPRYD4 | 1.15e-04 | 1136 | 101 | 12 | 34800366 |
| Pubmed | 1.19e-04 | 650 | 101 | 9 | 38777146 | ||
| Pubmed | Analysis of mouse embryonic patterning and morphogenesis by forward genetics. | 1.22e-04 | 33 | 101 | 3 | 15755804 | |
| Pubmed | 1.22e-04 | 652 | 101 | 9 | 31180492 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 28049720 | ||
| Cytoband | 12q24.11 | 5.37e-05 | 33 | 101 | 3 | 12q24.11 | |
| Cytoband | 17q22-q23 | 7.15e-05 | 6 | 101 | 2 | 17q22-q23 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | HK3 GART OBSCN ARHGEF17 LYST TF ITIH2 NRP2 DDX11 MSH6 ZFHX2 GNAO1 CDH4 SNTB1 | 1.03e-05 | 909 | 101 | 14 | M41018 |
| Coexpression | P53_DN.V1_DN | 1.04e-05 | 194 | 101 | 7 | M2697 | |
| Coexpression | GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP | 1.27e-05 | 200 | 101 | 7 | M5119 | |
| Coexpression | GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN | 1.27e-05 | 200 | 101 | 7 | M3365 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-07 | 170 | 101 | 7 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-07 | 170 | 101 | 7 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.37e-07 | 197 | 101 | 7 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.37e-07 | 197 | 101 | 7 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.37e-07 | 197 | 101 | 7 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.61e-07 | 199 | 101 | 7 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.61e-07 | 199 | 101 | 7 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.61e-07 | 199 | 101 | 7 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.83e-06 | 161 | 101 | 6 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-06 | 164 | 101 | 6 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-06 | 173 | 101 | 6 | f2eeff86e7dc7f4e3c36f775777d56685d7096cf | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.08e-06 | 185 | 101 | 6 | eac18ddcdac60b829619f7657e833d08cc9bcbab | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.76e-06 | 190 | 101 | 6 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.06e-06 | 192 | 101 | 6 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-06 | 196 | 101 | 6 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-06 | 196 | 101 | 6 | 624f700daea48d9bad4cc554f4776bd809ae1e54 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-06 | 196 | 101 | 6 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.03e-06 | 198 | 101 | 6 | 3222d064b6ecab0caa450a59fc1dc79e26fc6fd5 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.03e-06 | 198 | 101 | 6 | 6b8baa0b76242736f6dba482cdaad019256877ea | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.03e-06 | 198 | 101 | 6 | 8519c7bd5f6c5a97f5e43f4729b1411d3b07e4c8 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.21e-06 | 199 | 101 | 6 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.21e-06 | 199 | 101 | 6 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.21e-06 | 199 | 101 | 6 | 2c5ad62919c64ea0242e0984bb9932d2d975f4e3 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.21e-06 | 199 | 101 | 6 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.21e-06 | 199 | 101 | 6 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Vein|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | b3f93b71589251197cde96b7bc6d065c106f61cd | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 151 | 101 | 5 | e243b6c76e59035f10519a86399b598dd2123f87 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 151 | 101 | 5 | cdd2ce0969da446616627e3569bbe5a5d9b475bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 159 | 101 | 5 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-05 | 161 | 101 | 5 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 167 | 101 | 5 | 40d102e01ccbc7262d00fafd59ca5234909009cb | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-05 | 168 | 101 | 5 | 68ee3b3b012b56584e313813feb16e632e3f72d2 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 168 | 101 | 5 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 168 | 101 | 5 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | Adult-Immune-enucleated_erythrocyte-D122|Adult / Lineage, Cell type, age group and donor | 4.17e-05 | 169 | 101 | 5 | d5624e5b3687bd3f18f3a2b47a94d11eb1fbdb75 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.29e-05 | 170 | 101 | 5 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 170 | 101 | 5 | 064786c1f1ad7665358964765910b0ad46d14685 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 170 | 101 | 5 | dd48fd3c5c67eb71183981f42975a538f12077c3 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.29e-05 | 170 | 101 | 5 | 67e78e3c1d4cd3c6eaa5d0a9785b6cd8a3b08039 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 170 | 101 | 5 | 6725747df336697708b94999b3ebb40f1721da16 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 4.41e-05 | 171 | 101 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 172 | 101 | 5 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 172 | 101 | 5 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 172 | 101 | 5 | 33c201aaa98acbf1901b6fa6ce0d3ff8012a4d94 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.66e-05 | 173 | 101 | 5 | 1bf9c91c1803a540b5e43bc4280aab4289341cee | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 4.79e-05 | 174 | 101 | 5 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 4.79e-05 | 174 | 101 | 5 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-05 | 174 | 101 | 5 | 096bc6f1889f2bbadfe1e1a3eb6ae569aaa2ee7d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.92e-05 | 175 | 101 | 5 | 0ed053aa8353c72ff37fee830672704a3ddc7d85 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.92e-05 | 175 | 101 | 5 | 0124a3c4696b39cee8b566e94603d1d3d128bfa5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.92e-05 | 175 | 101 | 5 | e219b61d6bc078d44ea7d06191d3462654d857a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.92e-05 | 175 | 101 | 5 | bd16c80418bf71127e6f1e50edf83967c9218b42 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.06e-05 | 176 | 101 | 5 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.06e-05 | 176 | 101 | 5 | ce85a13e10cf37f5cf38ca8b0bac6701b6d00ffd | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-NK_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 177 | 101 | 5 | be35bb178fbc149f8a12984c012d98b486325ba9 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.20e-05 | 177 | 101 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.20e-05 | 177 | 101 | 5 | 84930899eb2978598bc8a351cbcd9e714e46799d | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 178 | 101 | 5 | 50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.48e-05 | 179 | 101 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.48e-05 | 179 | 101 | 5 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 5.63e-05 | 180 | 101 | 5 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 5.78e-05 | 181 | 101 | 5 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | mild_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 6.09e-05 | 183 | 101 | 5 | 9a4899afac0f91203209392c5f67b3d0aa356b86 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 6.09e-05 | 183 | 101 | 5 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.41e-05 | 185 | 101 | 5 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.57e-05 | 186 | 101 | 5 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.57e-05 | 186 | 101 | 5 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.57e-05 | 186 | 101 | 5 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.57e-05 | 186 | 101 | 5 | 701eea0016d69f0f9d29b613948f91239096e6c7 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.57e-05 | 186 | 101 | 5 | bcb3ac9f9b51346e0a2b0bda96d149b3c11f7883 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.74e-05 | 187 | 101 | 5 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 6.74e-05 | 187 | 101 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | droplet-Spleen-SPLEEN-1m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-05 | 188 | 101 | 5 | 713fbbd55d2853dee3df2336cada32c153cbd2a1 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-05 | 188 | 101 | 5 | 9fc3f17045606f1fe29d296326da9482db58433b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-05 | 188 | 101 | 5 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-05 | 188 | 101 | 5 | bf77e59b9001c7f7ca17f81073f935f281a25a1f | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-05 | 188 | 101 | 5 | 1ff13434dfe60c8184d5f33041e325eca41392bc | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-05 | 188 | 101 | 5 | b2472a294b25fc2f0da7f18519fdcb9ca166c6f0 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.09e-05 | 189 | 101 | 5 | 0daa8efac08dca9525d2b8d421952068cab4eb50 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 7.09e-05 | 189 | 101 | 5 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.09e-05 | 189 | 101 | 5 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.09e-05 | 189 | 101 | 5 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.09e-05 | 189 | 101 | 5 | b6bb4327b4560d07d2b728abcc5f144f428948a5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.27e-05 | 190 | 101 | 5 | 05e6af222d0ad97cb69f399a96c9038f9dd989b9 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 190 | 101 | 5 | 55be54c39ac9eb8e2c1515d8c212130ce2b0ef88 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 190 | 101 | 5 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.27e-05 | 190 | 101 | 5 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 190 | 101 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 190 | 101 | 5 | 24b78a6f2a763acb8f4e90a5d245c9c77605b426 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 190 | 101 | 5 | 6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-05 | 190 | 101 | 5 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 190 | 101 | 5 | e2fdbfaf08da3274b6bdda615386aa880040a90a | |
| ToppCell | COVID-19-Heart-Mito_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.27e-05 | 190 | 101 | 5 | ea74e0e38bcaba125b48c88331e9ba09228d3178 | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 7.45e-05 | 191 | 101 | 5 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| Drug | Clodronate | 8.22e-08 | 3 | 100 | 3 | DB00720 | |
| Drug | dehydroabietylamine | 3.28e-07 | 4 | 100 | 3 | ctd:C000600819 | |
| Drug | closantel | 2.84e-06 | 7 | 100 | 3 | ctd:C023342 | |
| Drug | phosphoenolpyruvate | 4.12e-06 | 210 | 100 | 8 | CID000001005 | |
| Drug | Ptpc | 4.32e-06 | 55 | 100 | 5 | CID003036276 | |
| Drug | AC1L4X2K | 9.65e-06 | 10 | 100 | 3 | CID000193824 | |
| Drug | glycine | 9.83e-06 | 169 | 100 | 7 | CID000000750 | |
| Drug | lonidamine | 1.30e-05 | 33 | 100 | 4 | CID000039562 | |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 2.40e-05 | 194 | 100 | 7 | 3680_UP | |
| Drug | glycerol;phosphate | 2.57e-05 | 79 | 100 | 5 | CID000082875 | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; HL60; HG-U133A | 2.74e-05 | 198 | 100 | 7 | 1412_UP | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.83e-05 | 199 | 100 | 7 | 3615_UP | |
| Drug | oleoylcarnitine | 4.42e-05 | 16 | 100 | 3 | CID006441392 | |
| Drug | GTP - Na | A2M NPR3 HK3 TAF1B ACSM1 ARHGEF17 LYST ADCY1 PGM1 CSK DHODH EEF2K GNAO1 KPNB1 | 5.07e-05 | 923 | 100 | 14 | CID000000762 |
| Drug | malate | 5.19e-05 | 219 | 100 | 7 | CID000000525 | |
| Drug | beta-hydroxypalmitoyl-CoA | 5.35e-05 | 17 | 100 | 3 | CID000440600 | |
| Drug | carboxyatractyloside | 5.71e-05 | 3 | 100 | 2 | ctd:C003853 | |
| Drug | CID5288005 | 5.88e-05 | 48 | 100 | 4 | CID005288004 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 1.42e-07 | 4 | 98 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 3.27e-05 | 3 | 98 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | optic cup area measurement | 3.68e-05 | 56 | 98 | 4 | EFO_0006940 | |
| Disease | Hypertrophic Cardiomyopathy | 3.95e-05 | 57 | 98 | 4 | C0007194 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 1.22e-04 | 29 | 98 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | systemic scleroderma | 1.88e-04 | 85 | 98 | 4 | EFO_0000717 | |
| Disease | bullous pemphigoid | 1.97e-04 | 34 | 98 | 3 | EFO_0007187 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 2.15e-04 | 35 | 98 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.17e-04 | 163 | 98 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Juvenile pauciarticular chronic arthritis | 2.27e-04 | 7 | 98 | 2 | C2931171 | |
| Disease | Adenocarcinoma of large intestine | 3.01e-04 | 96 | 98 | 4 | C1319315 | |
| Disease | retinal vasculature measurement | 3.33e-04 | 517 | 98 | 8 | EFO_0010554 | |
| Disease | hypothyroidism | 3.78e-04 | 284 | 98 | 6 | EFO_0004705 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.30e-04 | 291 | 98 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | Gastric Adenocarcinoma | 4.56e-04 | 45 | 98 | 3 | C0278701 | |
| Disease | response to ondansetron, QT interval | 5.89e-04 | 11 | 98 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | eye measurement, sun exposure measurement | 5.89e-04 | 11 | 98 | 2 | EFO_0004731, EFO_0010729 | |
| Disease | serum alanine aminotransferase measurement | DDX11 TENM4 ADAMTS9 DHODH TMEM147 PCDHGB4 N4BP2L2 GNAO1 ARHGEF4 NUDC | 6.31e-04 | 869 | 98 | 10 | EFO_0004735 |
| Disease | ovarian reserve | 7.05e-04 | 12 | 98 | 2 | EFO_0004770 | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 7.05e-04 | 12 | 98 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | cleft palate (is_implicated_in) | 7.05e-04 | 12 | 98 | 2 | DOID:674 (is_implicated_in) | |
| Disease | serum albumin measurement | 8.10e-04 | 592 | 98 | 8 | EFO_0004535 | |
| Disease | neuroimaging measurement | 8.46e-04 | 1069 | 98 | 11 | EFO_0004346 | |
| Disease | Non-steroidal anti-inflammatory and antirheumatic product use measurement | 1.11e-03 | 15 | 98 | 2 | EFO_0009935 | |
| Disease | glycine measurement | 1.15e-03 | 137 | 98 | 4 | EFO_0009767 | |
| Disease | cortical thickness | A2M FLNB TMEM170A DNAAF9 PGM1 NRP2 TNFSF11 CSK ADAMTS9 PCDHGB4 SNTB1 | 1.17e-03 | 1113 | 98 | 11 | EFO_0004840 |
| Disease | very low density lipoprotein cholesterol measurement | 1.78e-03 | 260 | 98 | 5 | EFO_0008317 | |
| Disease | cortical surface area change measurement, age at assessment | 1.80e-03 | 19 | 98 | 2 | EFO_0008007, EFO_0021503 | |
| Disease | Systemic Scleroderma | 1.80e-03 | 19 | 98 | 2 | C0036421 | |
| Disease | triglyceride measurement, body mass index | 1.80e-03 | 19 | 98 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | amino acid measurement | 1.91e-03 | 678 | 98 | 8 | EFO_0005134 | |
| Disease | polymyositis | 2.00e-03 | 20 | 98 | 2 | EFO_0003063 | |
| Disease | apolipoprotein A 1 measurement | 2.06e-03 | 848 | 98 | 9 | EFO_0004614 | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 2.12e-03 | 162 | 98 | 4 | EFO_0004612, EFO_0007878 | |
| Disease | Autoimmune Hepatitis | 2.20e-03 | 21 | 98 | 2 | EFO_0005676 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 2.24e-03 | 274 | 98 | 5 | EFO_0004530, EFO_0004612 | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 2.42e-03 | 22 | 98 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | Down syndrome (is_marker_for) | 2.42e-03 | 22 | 98 | 2 | DOID:14250 (is_marker_for) | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 2.42e-03 | 168 | 98 | 4 | EFO_0004329, EFO_0004612 | |
| Disease | Ovarian Serous Adenocarcinoma | 2.64e-03 | 23 | 98 | 2 | C1335177 | |
| Disease | Sarcosine measurement | 2.64e-03 | 23 | 98 | 2 | EFO_0021668 | |
| Disease | JT interval, response to sulfonylurea | 2.64e-03 | 23 | 98 | 2 | EFO_0007885, EFO_0007922 | |
| Disease | Lynch syndrome (is_implicated_in) | 2.87e-03 | 24 | 98 | 2 | DOID:3883 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LEKDFSIYGGELGPM | 631 | Q5FVE4 | |
| EMEDVGLLFARLGKY | 291 | Q15758 | |
| GMGGAFVLVLYDELK | 281 | P12236 | |
| EGLDYRDFESLGKGM | 551 | Q9BQT9 | |
| VDYGEFKRGIIGEMN | 501 | Q9BXY5 | |
| GMGGAFVLVLYDEIK | 281 | P05141 | |
| LYYKGRLDMDGLEVV | 541 | Q9NR80 | |
| IGKGEFGDVMLGDYR | 201 | P41240 | |
| FGDVMLGDYRGNKVA | 206 | P41240 | |
| IVEEGDMKGEVYPFG | 621 | O75534 | |
| LEIIEGMKFDRGYIS | 211 | P10809 | |
| EGLRVGFYESDVMGR | 701 | P01023 | |
| VIGDYFGKEGRFEMR | 431 | P17342 | |
| TLVVGGDGRFYMKEA | 56 | P36871 | |
| GDGRFYMKEAIQLIA | 61 | P36871 | |
| VGVMKELVERFALYG | 56 | Q5RL73 | |
| GFFEGELMDGRRGLV | 696 | O95153 | |
| VINEGGIDKLGEYME | 376 | Q96TA1 | |
| KEYSIVLEARDGGGM | 311 | Q9UN71 | |
| VISGGEGYIDFRMGD | 1271 | O60271 | |
| YMITDIIGKDDGLGV | 1891 | O00763 | |
| RPKMLVISGGDGYED | 2021 | Q96PE2 | |
| IKGMDVYGYLLAREG | 271 | Q9UJX3 | |
| GTRLLVFGGMVEYGK | 91 | P51610 | |
| AIYDIYGKRGLEMEG | 76 | Q9NVH1 | |
| MLGIYDGKRHLIFGE | 226 | O15481 | |
| GFMVGREYEAEGIAK | 406 | Q9HCC0 | |
| LGMGFDVDYDFLKRL | 451 | P19823 | |
| LLVKIGDFGMSRDVY | 691 | Q16288 | |
| KMYLGEGEVLVEGLV | 2841 | Q03001 | |
| LYLVMELVKGGDLFD | 461 | O15075 | |
| KVYGRGLSEGRTFEM | 2006 | O75369 | |
| DLGYGTLLERMKGEA | 96 | Q9HBL7 | |
| EEDRFYLVFEKMRGG | 151 | Q9HBH9 | |
| GGIEIFILTGMAYDR | 106 | Q8NGL7 | |
| IVMGFCEGGDLYRKL | 81 | P51957 | |
| RDDGIMYAKRLESAG | 351 | Q6PIU2 | |
| MEYQIVFEGVIGKGR | 766 | O60462 | |
| FMAELYRVLEAGKIG | 26 | Q96FC9 | |
| EYFREKLSDGIGVML | 641 | P52701 | |
| FEKMIGGLYLGELVR | 306 | P52790 | |
| EFMGRVFKYLGDKGV | 46 | Q8TCD6 | |
| SKGFDEYMKELGVGI | 16 | Q01469 | |
| LEEMKRLVGEIYGGH | 141 | Q7RTU3 | |
| YKDGMELGHSGERFL | 831 | Q5VST9 | |
| KGEMLTYFLEGRTDG | 1046 | Q08828 | |
| KGASEDGEYFLMIRG | 1746 | Q9P2N4 | |
| GELRLGKEGTDRYRM | 241 | Q969P0 | |
| DDMTEGDLGYGLGRK | 21 | Q86Z20 | |
| IMLDFGEKRGYLEAP | 51 | Q8NCX0 | |
| EVEDLLRKGAYGALM | 951 | Q8TD26 | |
| EAYSEIGMKGERRRG | 121 | P20963 | |
| FMAELYRVLEAGKIG | 26 | A8MPP1 | |
| PRFKKLADMYGGGEE | 901 | P55283 | |
| EGIGGDGFFTMKYEL | 191 | Q5TEA3 | |
| GELLLGKCGMYFVED | 3031 | Q99698 | |
| VEVLGGEFLKYMEAF | 636 | Q14974 | |
| GGEVFDYLVAHGRMK | 141 | Q9P0L2 | |
| RLKDGILFGMVGAYD | 381 | O75578 | |
| GGDFLYSDREIEVMK | 86 | Q9NTM9 | |
| EAEMLFTGGYGLEKD | 671 | O00418 | |
| EMEYKIVDGDGLGIF | 296 | Q9ULB5 | |
| GMDYRAVGKIFSGLA | 1861 | Q8IVF4 | |
| GASLLEDGRMKFDEY | 2351 | Q8IVF4 | |
| KYLIGEVMYGGRAID | 4081 | Q8IVF4 | |
| RYDMGILDLGSGDEK | 1141 | A3KN83 | |
| VKMGAPDAGLAEYLF | 216 | Q8N4E7 | |
| YRDGRKGGILADDMG | 111 | Q2NKX8 | |
| EFMGLIRGHYEAKQG | 341 | Q93099 | |
| DDGIRMLYLDFGGKD | 491 | Q13884 | |
| MLYLDFGGKDGEIQL | 496 | Q13884 | |
| FRDDMGVKYGLVGLE | 46 | Q8WW59 | |
| AGVYRAAGKEMIPFE | 106 | Q8WVE7 | |
| MKLYGRDRGIFGIES | 256 | Q53T94 | |
| RAMDTLGIEYGDKER | 86 | P09471 | |
| GEAVDGLYKMGFGFV | 101 | Q02127 | |
| IGMAALGYLRFGDDI | 311 | Q495M3 | |
| ERTALYGKFIDGEMI | 151 | Q8WTS6 | |
| YGKFIDGEMIEGKLA | 156 | Q8WTS6 | |
| EIGGFEEVKRRYMLA | 206 | P53794 | |
| MEELGEDRFGKVYKG | 476 | Q01974 | |
| IDMLEGAFYGLDLLK | 151 | Q68BL8 | |
| PEILQAMEDGKGRYG | 246 | Q5VT25 | |
| AEFGKYGRIVEVLLM | 26 | O75526 | |
| VMFLYDNGGGLVADE | 16 | P31271 | |
| LRRKTDFFIGGEEGM | 36 | Q9Y266 | |
| DFVKSGDYALERMGV | 881 | Q9UL12 | |
| VLEMIGEGSFGRVYK | 6 | Q9NRP7 | |
| LFGIYKSDFDRVGGM | 966 | Q76KP1 | |
| GMGGAFVLVLYDEIK | 281 | P12235 | |
| GDRGKMDEEGYICFL | 451 | Q08AH1 | |
| GDIGREMYIIKEGKL | 506 | P29973 | |
| RLMIKFRGEEGLDYG | 421 | Q9HAU4 | |
| MEGAGYRVVFEKGGV | 1 | Q9HA65 | |
| DAMSLDGGFVYIAGK | 406 | P02787 | |
| IYKFLLDMEGAEAGA | 851 | Q9C0A1 | |
| DMEKTGGRAYLRPEF | 166 | Q6IEE8 | |
| LGEFHIRMKGLVGYA | 201 | Q96MK2 | |
| DGYVMGFVSKEKERL | 571 | Q14765 | |
| DKFGLIYFVDGTMIR | 1356 | Q6N022 | |
| GEYDLAGFAVGAMER | 581 | P22102 | |
| RDYTKYLRGSEEMGG | 6 | O14788 | |
| EFVGKMLGKAVYEGI | 776 | Q7Z3V4 | |
| KMGYGIGTRLVEDFL | 46 | Q5T215 | |
| EGGIYDFIGEFMKAS | 61 | Q9BVK8 | |
| GRIDYDEFLEFMKGV | 146 | P63316 | |
| MSYGEIEGKFLGPRE | 1 | Q92802 |